MedTrace Logo

Interactive Exergaming With Otago Exercise Program on Mobility in Community-Dwelling Older Adults

NCT06814678 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-02-07

No results posted yet for this study

Summary

This clinical trial aims to evaluate the effectiveness of interactive exergaming combined with Otago Exercise Program on mobility among community-dwelling older adults aged 65 and above. The main research questions are:

Does this combined exercise intervention improve elderly mobility? Does this program enhance muscle strength and psychological well-being?

Researchers will compare two groups: one group will do the combined exercise program for 12 weeks, while the other group will continue their usual activities.

Participants will:

* Have their health checked three times: at the start, after 12 weeks, and 3 months later
* If in the exercise group, attend exercise sessions twice a week for 12 weeks
* Complete tests about their physical abilities and how they feel emotionally

Who can take part:

* Adults age 65 or older
* People who need more than 12 seconds to stand up and sit down 5 times
* People who can stand for at least 30 seconds with support

People cannot take part if they have serious vision problems, recent leg injuries, major illnesses, significant memory problems, or mental health conditions.

Conditions

  • Physical Functional Performance
  • Psychological Health
  • Physical Fitness
  • Mobility Limitation
  • Aging

Interventions

BEHAVIORAL

Interactive Exergaming with Otago Exercise Program

Participants will receive a 12-week structured program combining interactive exergaming and Otago Exercise Program. Sessions include balance training, strength exercises, and functional mobility activities delivered through interactive gaming platforms, supervised by trained instructors.

OTHER

Control Group with Usual Care

Participants will maintain their regular activities at community centers or facilities, including cognitive therapy, oral exercises, and upper limb training programs, during the 12-week study period

Sponsors & Collaborators

  • National Taiwan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-11
Primary Completion
2025-12-15
Completion
2026-03-31

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06814678 on ClinicalTrials.gov